These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 23514246)
21. Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial. Palma DA; Prisman E; Berthelet E; Tran E; Hamilton S; Wu J; Eskander A; Higgins K; Karam I; Poon I; Husain Z; Enepekides D; Hier M; Sultanem K; Richardson K; Mlynarek A; Johnson-Obaseki S; Odell M; Bayley A; Dowthwaite S; Jackson JE; Dzienis M; O'Neil J; Chandarana S; Banerjee R; Hart R; Chung J; Tenenholtz T; Krishnan S; Le H; Yoo J; Mendez A; Winquist E; Kuruvilla S; Stewart P; Warner A; Mitchell S; Chen J; Parker C; Wehrli B; Kwan K; Theurer J; Sathya J; Hammond JA; Read N; Venkatesan V; MacNeil SD; Fung K; Nichols AC JAMA Oncol; 2022 Jun; 8(6):1-7. PubMed ID: 35482348 [TBL] [Abstract][Full Text] [Related]
22. Utility of up-front transoral robotic surgery in tailoring adjuvant therapy. Gildener-Leapman N; Kim J; Abberbock S; Choby GW; Mandal R; Duvvuri U; Ferris RL; Kim S Head Neck; 2016 Aug; 38(8):1201-7. PubMed ID: 27225507 [TBL] [Abstract][Full Text] [Related]
23. Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized Trial. Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Johnson-Obaseki S; Odell M; Corsten M; Parker C; Wehrli B; Kwan K; Palma DA J Clin Oncol; 2024 Dec; 42(34):4023-4028. PubMed ID: 39303189 [TBL] [Abstract][Full Text] [Related]
24. The Role of Transoral Robotic Surgery in the Management of HPV Negative Oropharyngeal Squamous Cell Carcinoma. Sload R; Silver N; Jawad BA; Gross ND Curr Oncol Rep; 2016 Sep; 18(9):53. PubMed ID: 27469262 [TBL] [Abstract][Full Text] [Related]
25. Comparison of margins and survival between transoral robotic surgery (TORS) and non-robotic endoscopic surgery for oropharyngeal cancer. Groysman M; Gleadhill C; Baker A; Wang SJ; Bearelly S Am J Otolaryngol; 2023; 44(6):103982. PubMed ID: 37531886 [TBL] [Abstract][Full Text] [Related]
26. Utilization of Transoral Robotic Surgery (TORS) in patients with Oropharyngeal Squamous Cell Carcinoma and its impact on survival and use of chemotherapy. Baliga S; Kabarriti R; Jiang J; Mehta V; Guha C; Kalnicki S; Smith RV; Garg MK Oral Oncol; 2018 Nov; 86():75-80. PubMed ID: 30409323 [TBL] [Abstract][Full Text] [Related]
27. Transoral robotic surgery for oropharyngeal squamous cell carcinoma. Schmitt NC; Duvvuri U Curr Opin Otolaryngol Head Neck Surg; 2015 Apr; 23(2):127-31. PubMed ID: 25692632 [TBL] [Abstract][Full Text] [Related]
28. Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma. Amin DR; Philips R; Bertoni DG; Mastrolonardo EV; Campbell DJ; Agarwal AM; Tekumalla S; Urdang ZD; Luginbuhl AJ; Cognetti DM; Curry JM JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):980-986. PubMed ID: 37422846 [TBL] [Abstract][Full Text] [Related]
29. A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx. Albergotti WG; Jordan J; Anthony K; Abberbock S; Wasserman-Wincko T; Kim S; Ferris RL; Duvvuri U Cancer; 2017 Aug; 123(16):3132-3140. PubMed ID: 28467606 [TBL] [Abstract][Full Text] [Related]
30. Transoral robotic surgery alone for oropharyngeal cancer: quality-of-life outcomes. Choby GW; Kim J; Ling DC; Abberbock S; Mandal R; Kim S; Ferris RL; Duvvuri U JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):499-504. PubMed ID: 25834991 [TBL] [Abstract][Full Text] [Related]
31. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation. Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038 [TBL] [Abstract][Full Text] [Related]
32. Long-term survival outcomes after primary transoral robotic surgery (TORS) with concurrent neck dissection for early-stage oropharyngeal squamous cell carcinoma. Frederiksen JG; Channir HI; Larsen MHH; Christensen A; Friborg J; Charabi BW; Rubek N; von Buchwald C Acta Otolaryngol; 2021 Jul; 141(7):714-718. PubMed ID: 34191671 [TBL] [Abstract][Full Text] [Related]
33. Optimized decision support for selection of transoral robotic surgery or (chemo)radiation therapy based on posttreatment swallowing toxicity. Hemmati M; Barbon C; Mohamed ASR; van Dijk LV; Moreno AC; Gross ND; Goepfert RP; Lai SY; Hutcheson KA; Schaefer AJ; Fuller CD; Cancer Med; 2023 Feb; 12(4):5088-5098. PubMed ID: 36229990 [TBL] [Abstract][Full Text] [Related]
34. Preservation of swallowing in resected oral cavity squamous cell carcinoma: examining radiation volume effects (PRESERVE): study protocol for a randomized phase II trial. Lang P; Contreras J; Kalman N; Paterson C; Bahig H; Billfalk-Kelly A; Brennan S; Rock K; Read N; Venkatesan V; Sathya J; Mendez LC; MacNeil SD; Nichols AC; Fung K; Mendez A; Winquist E; Kuruvilla S; Stewart P; Warner A; Mitchell S; Theurer JA; Palma DA Radiat Oncol; 2020 Aug; 15(1):196. PubMed ID: 32795322 [TBL] [Abstract][Full Text] [Related]
35. Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base. Cracchiolo JR; Baxi SS; Morris LG; Ganly I; Patel SG; Cohen MA; Roman BR Cancer; 2016 May; 122(10):1523-32. PubMed ID: 26970050 [TBL] [Abstract][Full Text] [Related]
36. Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma. Sinclair CF; McColloch NL; Carroll WR; Rosenthal EL; Desmond RA; Magnuson JS Arch Otolaryngol Head Neck Surg; 2011 Nov; 137(11):1112-6. PubMed ID: 22106235 [TBL] [Abstract][Full Text] [Related]
37. De-Escalated Adjuvant Therapy After Transoral Robotic Surgery for Human Papillomavirus-Related Oropharyngeal Carcinoma: The Sinai Robotic Surgery (SIRS) Trial. Miles BA; Posner MR; Gupta V; Teng MS; Bakst RL; Yao M; Misiukiewicz KJ; Chai RL; Sharma S; Westra WH; Kim-Schulze S; Dayal B; Sobotka S; Sikora AG; Som PM; Genden EM Oncologist; 2021 Jun; 26(6):504-513. PubMed ID: 33675133 [TBL] [Abstract][Full Text] [Related]
38. Functional outcomes, feasibility, and safety of resection of transoral robotic surgery: single-institution series of 35 consecutive cases of transoral robotic surgery for oropharyngeal squamous cell carcinoma. Lörincz BB; Möckelmann N; Busch CJ; Knecht R Head Neck; 2015 Nov; 37(11):1618-24. PubMed ID: 24955923 [TBL] [Abstract][Full Text] [Related]
39. Management of Recurrent and Metastatic HPV-Positive Oropharyngeal Squamous Cell Carcinoma after Transoral Robotic Surgery. Sims JR; Van Abel K; Martin EJ; Lohse CM; Price DL; Olsen KD; Moore EJ Otolaryngol Head Neck Surg; 2017 Jul; 157(1):69-76. PubMed ID: 28374634 [TBL] [Abstract][Full Text] [Related]
40. Transoral robotic versus open surgical approaches to oropharyngeal squamous cell carcinoma by human papillomavirus status. Ford SE; Brandwein-Gensler M; Carroll WR; Rosenthal EL; Magnuson JS Otolaryngol Head Neck Surg; 2014 Oct; 151(4):606-11. PubMed ID: 25049265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]